bogga_banner

2019-nCoV S-RBD Dhexdhexaadinta Qalabka Tijaabada Kahortagga Jirka (qaabka dahabka kolloyalka)

2019-nCoV S-RBD Dhexdhexaadinta Qalabka Tijaabada Kahortagga Jirka (qaabka dahabka kolloyalka)

Sharaxaad Gaaban:

Ku habboon

Fas

Isticmaal duurjoogta ah


Faahfaahinta Alaabta

SAWIRRO

Download

Tags Product

Hordhac

Waqtigan xaadirka ah, dhammaan tallaallada musharraxiinta ee 2019-nCoV ee horumarinta kiliinikada waxaa lagu maamulaa duritaanka muruqa.Talaalka muruqa ama maqaarka hoose wuxuu u horseedi karaa kicin xoog leh oo ah serum IgG
In ka badan 180 musharax oo tallaal, oo ku saleysan dhowr goobood oo kala duwan ayaa hadda ku jira horumar ka dhan ah 2019-nCoV.
borotiinka S waa bartilmaameedka ugu weyn ee ka hortagga unugyada difaaca;
Qaar badan oo ka mid ah unugyada difaaca jirka waxay beegsadaan RBD ee borotiinka S.

Sida loo qiimeeyo waxtarka tallaalka 2019-nCoV? --- Dhexdhexaadinta Qalabka Tijaabada Kahortagga Jirka

Faa'iidada

Baaritaanka tallaalka ka hor
Kahor tallaalka, musharrixiinta waxay ogaan karaan antibody-ka-hortagga RBD si loo go'aamiyo haddii tallaalku lagama maarmaan yahay;

Inta badan tallaalada waa la daboolay
Waxay ogaan kartaa ka-hortagga difaaca jirka ee ay soo saaraan inta badan tallaalada suuqa;

Degdeg ah oo ku habboon
Qalliinku waa sahlan yahay, qalab lagu ogaanayo looma baahna, natiijooyinka waxaa lagu heli karaa 15 daqiiqo gudahood.

Shaqada aqoonsiga
Waxay kala saari kartaa kahortaga difaaca jirka ee 2019-nCoV ee uu soo saaray tallaalka 2019-nCoV ama ka-hortagga uu soo saaray caabuqa 2019-nCoV ee nooc ka mid ah tallaallada, sida tallaalka Viral vector (aan-ku-dabayn), tallaalka saldhigga RNA iyo tallaalka borotiinka hoosaadka. ;

Baaritaanka dhiigga oo dhan
Tijaabada dhiigga oo dhan ayaa ka dhigaysa qalliinka mid ku habboon;

Baaxadda codsiga

Tallaalka ka hor
Go'aanso haddii ay qaadeen cudurka 'coronavirus' cusub iyo inay weli u baahan yihiin in la tallaalo;

Muddada tallaalka
Go'aanso in antibody-ka-hortagga cusub la soo saaray iyo in kale;

Marxaladda dambe ee tallaalka
Marka loo eego aagga cudurka faafa ee 2019-nCoV, waxaa la soo jeediyay in la ogaado jiritaanka 2019-nCoV ka-hortagga kahortagga si joogto ah saddexdii biloodba mar.

Qaybaha

Qaybaha Waxyaabaha ugu muhiimsan Tirada soo darida (Tirada)
1 T/Kit 20 T/Kit 50 T/Qalabka
Kaarka tijaabada Xariijimo tijaabo ah oo ka kooban dahab kolloidal ah oo lagu sumadeeyay kahortaga-bini'aadamka IgG antibody, dahab kolloidle ah oo ku suntan anti-digaag IgY antibody, 2019-nCoV S-RBD borotiinka dib u habeynta, Digaag IgY antibody 1 pc 20 pcs 50 pcs
Tusaalaha lagu qasi karo 0.01M Fosfate xalinta, 0.5% Tween-20 0.5ml 5ml 10ml

Waxqabadka

Hecin reagent Baaritaanka dhexdhexaadinta fayraska serum ee bukaan-socodka Wadarta
Wanagsan xun
Wanagsan Wanagsan 84 9
xun xun 8 198
Wadarta Wadarta 92 207
Dareenka bukaan socodka Dareenka bukaan socodka 84/92 91.30% (95% CI: 83.58%96.17%)
Gaar ahaan bukaan-socodka Gaar ahaan bukaan-socodka 198/207 95.65% (95%CI: 91.91%97.99%)
Saxnaanta Saxnaanta 282/299 94.31% (95% CI: 91.05%96.65%)

 Waxqabadka Hecin reagent ee lidka ku ah Habka Isbarbardhigga ee shaybaarrada serum/plasma.

Hecin reagent Baaritaanka dhexdhexaadinta fayraska serum ee bukaan-socodka Wadarta
Wanagsan xun
Wanagsan 84 8 92
xun 8 199 207
Wadarta 92 207 299
Dareenka bukaan socodka 84/92 91.30% (95% CI: 83.58%96.17%)
Gaar ahaan bukaan-socodka 199/207 96.14% (95% CI: 92.53%98.32%)
Saxnaanta 283/299 94.65% (95% CI: 91.46%96.91%)

Waxqabadka Hecin reagent ka dhanka ah Habka Isbarbardhigga ee shaybaarada dhiigga oo dhan.

Habka Imtixaanka

Habka Imtixaanka-2
Habka Imtixaanka

Shahaadada Diiwaangelinta

S-RBD-CEPage3
CE-IVDD DOC 2019-nCoV S-RBD Dhexdhexaadinta Kahortagga -saxiixay (1)
IVDD DOC 2019-nCoV S-RBD Dhexdhexaadinta Kahortagayaasha - saxeexay

  • Hore:
  • Xiga:

  • JT08-1T

    1T9 1T1 1T2 1T3 1T4 1T5 1T6 1T7 1T8

     

     

    JT08-5T

    5T10 5T1 5T2 5T3 5T4 5T5 5T6 5T7 5T8 5T9

     

     

    JT08-50T

    50T5 50T1 50T2 50T3 50T4

    Halkan ku qor fariintaada oo noo soo dir